APOTHECARY DEVELOPMENTS LTD

Company Registration Number:
12931903 (England and Wales)

Unaudited micro entity accounts for the year ended 31 October 2023

Period of accounts

Start date: 01 November 2022

End date: 31 October 2023

APOTHECARY DEVELOPMENTS LTD

Contents of the Financial Statements

for the Period Ended 31 October 2023

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

APOTHECARY DEVELOPMENTS LTD

Company Information

for the Period Ended 31 October 2023




Registered office: Apothecary House
1 East Street
Rye
Sussex
GBR
TN31 7JY
Company Registration Number: 12931903 (England and Wales)

APOTHECARY DEVELOPMENTS LTD

Profit and Loss Account

for the Period Ended 31 October 2023


2023
£

2022
£
Turnover 18,119 17,442
Income from coronavirus (COVID-19) business support grants 0 4,763
Other Income 14 447
Cost of Materials ( 0 ) ( 0 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 312 ) ( 417 )
Other charges ( 11,254 ) ( 13,201 )
Tax on Profit ( 1,307 ) ( 1,796 )
Profit or (Loss) for Period 5,260 7,238

APOTHECARY DEVELOPMENTS LTD

Balance sheet

As at 31 October 2023


2023
£

2022
£
Called up share capital not paid: 0 0
Fixed Assets: 125,000 125,000
Current assets: 22,514 42,175
Prepayments and accrued income: 0 1,441
Creditors: amounts falling due within one year: ( 55,998 ) ( 87,137 )
Net current assets (liabilities): ( 33,484 ) ( 43,521 )
Total assets less current liabilities: 91,516 81,479
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 5,200 ) ( 425 )
Total net assets (liabilities): 86,316 81,054
Capital and reserves: 86,316 81,054

APOTHECARY DEVELOPMENTS LTD

Balance sheet continued

For the year ending 31 October 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 17 November 2023
And Signed On Behalf Of The Board By:

Name: Trevor Esdaile
Status: Director

The notes form part of these financial statements

APOTHECARY DEVELOPMENTS LTD

Footnotes to the Financial Statements

for the Period Ended 31 October 2023

  • 1. Employee Information

    Average number of employees: 2

APOTHECARY DEVELOPMENTS LTD

Footnotes to the Financial Statements

for the Period Ended 31 October 2023

  • 2. Off balance sheet disclosure

    No